IGBA Sets Out Industry Vision To 2030
Comprehensive Whitepaper Highlights Headwinds And Opportunities
A whitepaper setting out a comprehensive vision for the off-patent industry to 2030 has been launched by the IGBA. Highlighting the industry’s current contribution to healthcare, it also sets out a path ahead for the generics and biosimilars sector, pointing out headwinds as well as opportunities.
